Based on the results from HIV infection of HTOC CD4+ T cells in vitro (Fig. 2), we hypothesized that Th17 cells may also be reduced in the oral mucosa of HIV+ patients even after cART therapy. The gene discussed is CD4; the disease is HIV infectious disease.